Become a student member today for free and be part of the RACGP community
2022.1 CCE results release: Thursday 4 August 2022.
Live and practise medicine in Australia
RACGP offer courses and events to further develop the knowledge you need to develop your GP career
Discover a world of educational opportunities to support your lifelong learning
The RACGP is working hard on transitioning to college-led general practice training
Become a provider with the CPD Program and be recognised for the quality education and training you offer GPs
The Abuse and violence: working with our patients in general practice provides the best-available current evidence for GPs
Stay up-to-date with the latest information and resources on the COVID-19 vaccine rollout.
Download the Standards for general practice (5th edition) - a benchmark for quality care and risk management in Australian general practices
Coronavirus (COVID-19) resources for general practitioners
Advice and guidelines for GPs and practice teams to help protect general practice information systems
Video consultations can provide convenient and accessible healthcare delivery
Read all of the RACGP reports and submissions on various healthcare topics
Read all of the RACGP position statements on various healthcare topics
Join our RACGP Facebook groups
Early detection of cancers
Not recommended as a preventive activity
Screening of asymptomatic (low-risk) men for prostate cancer by prostate specific antigen (PSA) testing is not recommended because the benefits have not clearly been shown to outweigh the harms.1 This remains the case following recent large trials.1 Therefore, GPs have no obligation to offer prostate cancer screening to asymptomatic men.
Some men may have individual concerns about prostate cancer and may put a higher value on the possible benefits of prostate cancer screening. This requires specific discussion to address the benefits and harms (from overdiagnosis and overtreatment) of prostate cancer screening.2 The Royal Australian College of General Practitioners (RACGP) has produced a patient decision aid that may assist this discussion
If after an informed process, perhaps using a decision aid, a man still requests prostate cancer screening, a PSA blood test is acceptable.3 Digital rectal examination (DRE) is no longer recommended as it is insufficiently sensitive to detect prostate cancers early enough.4
Clinicians should not test for asymptomatic prostate cancer (eg by adding the PSA test to a battery of other tests) without counselling about possible harms as well as possible benefits, and obtaining informed consent.
Patients who request testing should be informed about the risks and benefits of tests for prostate cancer, and should be assisted to make their own decision using an acceptable decision aid.16
Did you know you can now log your CPD with a click of a button?
Appendix 13A - The 3 Incontinence Questions 3IQ (PDF 0.04 MB)
Appendix 2A - Family history screening questionnaire (PDF 0.03 MB)
Appendix 2B -Dutch Lipid Clinic Network Criteria for making a diagnosis of familial hypercholestrolaemia in adults (PDF 0.04 MB)
Appendix 3A - 'Red-flag' early intervention referral guide (PDF 0.37 MB)
Appendix 8A - Australian cardiovascular disease risk charts (PDF 0.47 MB)
Lifecycle charts (PDF 0.08 MB)
Donate to the RACGP Foundation today and influence the future of general practice